HEADER HYDROLASE/HYDROLASE INHIBITOR 15-MAR-13 4JNC TITLE SOLUBLE EPOXIDE HYDROLASE COMPLEXED WITH A CARBOXAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL EPOXIDE HYDROLASE 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: CYTOSOLIC EPOXIDE HYDROLASE 2, CEH, EPOXIDE HYDRATASE, COMPND 6 SOLUBLE EPOXIDE HYDROLASE, SEH, LIPID-PHOSPHATE PHOSPHATASE; COMPND 7 EC: 3.3.2.10, 3.1.3.76; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EPHX2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24 KEYWDS EPOXIDE HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.M.SHEWCHUK REVDAT 3 20-SEP-23 4JNC 1 REMARK REVDAT 2 24-FEB-21 4JNC 1 REMARK SEQADV REVDAT 1 05-JUN-13 4JNC 0 JRNL AUTH R.K.THALJI,J.J.MCATEE,S.BELYANSKAYA,M.BRANDT,G.D.BROWN, JRNL AUTH 2 M.H.COSTELL,Y.DING,J.W.DODSON,S.H.EISENNAGEL,R.E.FRIES, JRNL AUTH 3 J.W.GROSS,M.R.HARPEL,D.A.HOLT,D.I.ISRAEL,L.J.JOLIVETTE, JRNL AUTH 4 D.KROSKY,H.LI,Q.LU,T.MANDICHAK,T.ROETHKE,C.G.SCHNACKENBERG, JRNL AUTH 5 B.SCHWARTZ,L.M.SHEWCHUK,W.XIE,D.J.BEHM,S.A.DOUGLAS,A.L.SHAW, JRNL AUTH 6 J.P.MARINO JRNL TITL DISCOVERY OF 1-(1,3,5-TRIAZIN-2-YL)PIPERIDINE-4-CARBOXAMIDES JRNL TITL 2 AS INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 3584 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23664879 JRNL DOI 10.1016/J.BMCL.2013.04.019 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.48 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 23361 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1254 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.96 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.01 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1493 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.66 REMARK 3 BIN R VALUE (WORKING SET) : 0.3040 REMARK 3 BIN FREE R VALUE SET COUNT : 85 REMARK 3 BIN FREE R VALUE : 0.3550 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2478 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 238 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.18000 REMARK 3 B22 (A**2) : -0.11000 REMARK 3 B33 (A**2) : 0.29000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.179 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.152 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.092 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.002 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2635 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3595 ; 0.970 ; 1.963 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 329 ; 5.181 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 117 ;32.797 ;24.017 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 432 ;11.851 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;13.461 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 375 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2033 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1586 ; 0.282 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2561 ; 0.540 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1049 ; 0.774 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1025 ; 1.311 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 237 A 548 REMARK 3 RESIDUE RANGE : A 701 A 938 REMARK 3 ORIGIN FOR THE GROUP (A): -10.3060 19.0320 -15.3560 REMARK 3 T TENSOR REMARK 3 T11: 0.0222 T22: 0.0360 REMARK 3 T33: 0.0537 T12: 0.0088 REMARK 3 T13: -0.0056 T23: -0.0022 REMARK 3 L TENSOR REMARK 3 L11: 0.8682 L22: 0.6488 REMARK 3 L33: 1.0977 L12: 0.0061 REMARK 3 L13: -0.0822 L23: 0.0561 REMARK 3 S TENSOR REMARK 3 S11: -0.0099 S12: -0.0210 S13: 0.0620 REMARK 3 S21: 0.0229 S22: 0.0046 S23: 0.0304 REMARK 3 S31: -0.1157 S32: -0.0280 S33: 0.0053 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4JNC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAR-13. REMARK 100 THE DEPOSITION ID IS D_1000078262. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-SEP-07 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23361 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 60.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 33.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.19000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1VJ5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350, 0.1 M BISTRIS, 0.2M REMARK 280 NH4OAC, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 40.14250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.97550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.14250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.97550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 549 REMARK 465 ALA A 550 REMARK 465 ASP A 551 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 247 NE CZ NH1 NH2 REMARK 470 ARG A 353 CZ NH1 NH2 REMARK 470 LYS A 376 CG CD CE NZ REMARK 470 ASN A 378 CG OD1 ND2 REMARK 470 SER A 418 OG REMARK 470 LYS A 421 CG CD CE NZ REMARK 470 GLU A 424 CG CD OE1 OE2 REMARK 470 LYS A 456 CG CD CE NZ REMARK 470 SER A 457 OG REMARK 470 GLN A 502 CD OE1 NE2 REMARK 470 ARG A 547 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 548 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 269 -143.87 -119.64 REMARK 500 ASP A 335 -126.53 62.29 REMARK 500 ASN A 359 -43.56 78.23 REMARK 500 VAL A 498 -60.88 -104.15 REMARK 500 SER A 544 -89.57 -122.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 291 ASP A 292 146.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1LF A 601 DBREF 4JNC A 238 549 UNP P34913 HYES_HUMAN 238 549 SEQADV 4JNC GLY A 237 UNP P34913 EXPRESSION TAG SEQADV 4JNC ALA A 550 UNP P34913 EXPRESSION TAG SEQADV 4JNC ASP A 551 UNP P34913 EXPRESSION TAG SEQRES 1 A 315 GLY SER HIS GLY TYR VAL THR VAL LYS PRO ARG VAL ARG SEQRES 2 A 315 LEU HIS PHE VAL GLU LEU GLY SER GLY PRO ALA VAL CYS SEQRES 3 A 315 LEU CYS HIS GLY PHE PRO GLU SER TRP TYR SER TRP ARG SEQRES 4 A 315 TYR GLN ILE PRO ALA LEU ALA GLN ALA GLY TYR ARG VAL SEQRES 5 A 315 LEU ALA MET ASP MET LYS GLY TYR GLY GLU SER SER ALA SEQRES 6 A 315 PRO PRO GLU ILE GLU GLU TYR CYS MET GLU VAL LEU CYS SEQRES 7 A 315 LYS GLU MET VAL THR PHE LEU ASP LYS LEU GLY LEU SER SEQRES 8 A 315 GLN ALA VAL PHE ILE GLY HIS ASP TRP GLY GLY MET LEU SEQRES 9 A 315 VAL TRP TYR MET ALA LEU PHE TYR PRO GLU ARG VAL ARG SEQRES 10 A 315 ALA VAL ALA SER LEU ASN THR PRO PHE ILE PRO ALA ASN SEQRES 11 A 315 PRO ASN MET SER PRO LEU GLU SER ILE LYS ALA ASN PRO SEQRES 12 A 315 VAL PHE ASP TYR GLN LEU TYR PHE GLN GLU PRO GLY VAL SEQRES 13 A 315 ALA GLU ALA GLU LEU GLU GLN ASN LEU SER ARG THR PHE SEQRES 14 A 315 LYS SER LEU PHE ARG ALA SER ASP GLU SER VAL LEU SER SEQRES 15 A 315 MET HIS LYS VAL CYS GLU ALA GLY GLY LEU PHE VAL ASN SEQRES 16 A 315 SER PRO GLU GLU PRO SER LEU SER ARG MET VAL THR GLU SEQRES 17 A 315 GLU GLU ILE GLN PHE TYR VAL GLN GLN PHE LYS LYS SER SEQRES 18 A 315 GLY PHE ARG GLY PRO LEU ASN TRP TYR ARG ASN MET GLU SEQRES 19 A 315 ARG ASN TRP LYS TRP ALA CYS LYS SER LEU GLY ARG LYS SEQRES 20 A 315 ILE LEU ILE PRO ALA LEU MET VAL THR ALA GLU LYS ASP SEQRES 21 A 315 PHE VAL LEU VAL PRO GLN MET SER GLN HIS MET GLU ASP SEQRES 22 A 315 TRP ILE PRO HIS LEU LYS ARG GLY HIS ILE GLU ASP CYS SEQRES 23 A 315 GLY HIS TRP THR GLN MET ASP LYS PRO THR GLU VAL ASN SEQRES 24 A 315 GLN ILE LEU ILE LYS TRP LEU ASP SER ASP ALA ARG ASN SEQRES 25 A 315 PRO ALA ASP HET 1LF A 601 29 HETNAM 1LF 1-[4-METHYL-6-(METHYLAMINO)-1,3,5-TRIAZIN-2-YL]-N-[2- HETNAM 2 1LF (TRIFLUOROMETHYL)BENZYL]PIPERIDINE-4-CARBOXAMIDE FORMUL 2 1LF C19 H23 F3 N6 O FORMUL 3 HOH *238(H2 O) HELIX 1 1 SER A 270 ARG A 275 5 6 HELIX 2 2 TYR A 276 ALA A 284 1 9 HELIX 3 3 GLU A 304 TYR A 308 5 5 HELIX 4 4 CYS A 309 GLY A 325 1 17 HELIX 5 5 ASP A 335 TYR A 348 1 14 HELIX 6 6 SER A 370 LYS A 376 1 7 HELIX 7 7 ASN A 378 PHE A 381 5 4 HELIX 8 8 ASP A 382 PHE A 387 1 6 HELIX 9 9 GLY A 391 ASN A 400 1 10 HELIX 10 10 ASN A 400 PHE A 409 1 10 HELIX 11 11 ALA A 411 SER A 415 5 5 HELIX 12 12 SER A 418 HIS A 420 5 3 HELIX 13 13 LYS A 421 GLY A 426 1 6 HELIX 14 14 THR A 443 LYS A 456 1 14 HELIX 15 15 PHE A 459 TRP A 465 1 7 HELIX 16 16 ASN A 468 LYS A 478 1 11 HELIX 17 17 VAL A 500 GLN A 505 5 6 HELIX 18 18 HIS A 506 TRP A 510 5 5 HELIX 19 19 TRP A 525 LYS A 530 1 6 HELIX 20 20 LYS A 530 ASP A 543 1 14 SHEET 1 A 8 SER A 238 LYS A 245 0 SHEET 2 A 8 VAL A 248 LEU A 255 -1 O PHE A 252 N GLY A 240 SHEET 3 A 8 ARG A 287 MET A 291 -1 O VAL A 288 N LEU A 255 SHEET 4 A 8 ALA A 260 CYS A 264 1 N VAL A 261 O LEU A 289 SHEET 5 A 8 ALA A 329 HIS A 334 1 O VAL A 330 N CYS A 262 SHEET 6 A 8 VAL A 352 LEU A 358 1 O LEU A 358 N GLY A 333 SHEET 7 A 8 ALA A 488 ALA A 493 1 O VAL A 491 N SER A 357 SHEET 8 A 8 LYS A 515 ILE A 519 1 O LYS A 515 N ALA A 488 CISPEP 1 PHE A 267 PRO A 268 0 -9.14 SITE 1 AC1 13 PHE A 267 ASP A 335 TRP A 336 MET A 339 SITE 2 AC1 13 PHE A 381 TYR A 383 LEU A 408 MET A 419 SITE 3 AC1 13 TYR A 466 LEU A 499 HIS A 524 TRP A 525 SITE 4 AC1 13 HOH A 760 CRYST1 80.285 91.951 45.870 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012456 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010875 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021801 0.00000